Countries Hong Kong
"As the first market in Asia, we are pleased to bring to Hong Kong this medication for migraine, as we understand how migraine can adversely...
October 02, 2023 | News
The upcoming study, known as a randomized, double-blind, global multi-center Phase II study, is set to be conducted in the United States. Based on th...
September 29, 2023 | News
We were honored to have insightful keynote speeches delivered by renowned individuals, including: Mr. CY Leung, Vice Chairman of CPPCC Dr. Bruce B...
September 28, 2023 | News
First pneumococcal conjugate vaccine that fights against 20 serotypes leading to most of the invasive pneumococcal diseases and pneumonia[2],[3] &md...
August 11, 2023 | News
The agreement further builds upon the strategic collaboration the companies announced in April 2023. Under the terms of the agreements, DualityBio will re...
August 08, 2023 | News
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related...
August 07, 2023 | News
At the summit, Great Bay Bio announced the official launch of its self-developed AI-enabled, no-screening culture media development platform, AlfaOPA&trade...
August 04, 2023 | News
Currently, the Company's nanobathing products have been granted an invention patent and four utility model patents. Among them, one medical nanobathing car...
August 04, 2023 | News
Alma Veil is the core instrument equipped with three gold-standard technologies conveniently integrated into a single handpiece: 532 nm laser:...
July 26, 2023 | News
Insilico Medicine merges nebulizer device with AI-driven drug discovery; Potential advantages for the inhalation solution include a smaller effe...
July 24, 2023 | News
To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervi...
July 24, 2023 | News
- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...
July 18, 2023 | News
XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdo...
July 17, 2023 | News
EDIRNA is a start-up biotech company focusing on RNA-Editing therapeutics and taking advantage of the Group's proprietary technology platforms for novel RN...
July 06, 2023 | News
Most Read
Bio Jobs
News